Xia, Y., Cai, Q., Zhuang, D., Nie, M., Yang, H., Liu, H., Jiang, Y., Yang, S. (2025). Zanubrutinib plus R-CHOP versus R-CHOP as first-line therapy in double-expressor DLBCL: A multicenter, propensity score matched retrospective study. Blood. https://doi.org/10.1182/blood-2025-7202